Used in pharmaceutical research as a key intermediate in the synthesis of serotonin receptor modulators, particularly targeting 5-HT1A and 5-HT2A receptors. Its fluorinated structure enhances binding affinity and metabolic stability, making it valuable in developing central nervous system (CNS) agents for treating anxiety, depression, and schizophrenia. Also explored in the design of selective kinase inhibitors for oncology applications due to its rigid polycyclic framework that supports target specificity.